Enterprise expectations from cloud enablement are shifting from efficiency gains to overall business transformation benefits. Enterprises are also increasingly realizing that a cookie-cutter approach to the cloud will diminish the returns on their technology investments. Consequently, they are demanding depth of vertical expertise and customization capabilities from their technology providers to complement existing applications and address their pain points off-the-shelf. A cloud solution stack, which has been optimized and customized to fit the specific needs of a particular industry’s customers, can reduce compliance and regulatory risks, accelerate innovation, and efficiently handle data sources and business workflows. This study explores the concept of industry cloud as a critical enabler of cloud-first transformation strategies. We define industry cloud and explain the architectural stacks that will enable industry cloud adoption. We also present a framework with actionable steps to guide industry cloud adoption within enterprise IT environments. Further, the study provides industry cloud models for manufacturing and hi-tech firms. Scope: Industry: IT cloud services Geography: global Contents: In this viewpoint, we examine: The shift in enterprise cloud strategy Industry cloud’s market definition Industry cloud’s value proposition An enterprise cloud adoption guide Industry cloud adoption for manufacturing and hi-tech industries Membership (s) Cloud and Infrastructure Services Sourcing and Vendor Management

Sustainability initiatives are collective efforts and programs built around Environment, Social, and Governance (ESG) strategies. These initiatives closely tie with all three aspects of the triple bottom line comprising people, planet, and profits. In recent times, the focus on ESG has increased across industries, and life sciences is no exception. In fact, from its inception, the life sciences industry has sought to make a difference in the lives of patients and communities worldwide. However, sustainability-related themes and ESG efforts have gained strong traction during and after the pandemic. Investors, patients, and regulatory bodies are now demanding greater responsibility from life sciences enterprises, pushing them to broaden their sustainability initiatives. In this viewpoint, we highlight the growing importance of sustainability in the life sciences industry, focusing on social sustainability as the key driver to build a purpose-driven ecosystem. The research will also assist enterprises in prioritizing sustainability initiatives and adopting a phased approach to become truly purpose-led organizations. Scope Industry: life sciences Geography: global Contents In this viewpoint, we: Highlight the growing importance of sustainability in the life sciences industry Share Everest Group’s sustainability maturity framework Focus on social sustainability and help enterprises prioritize initiatives Recommend a phased approach to continuously generate value from sustainability initiatives Membership(s) Life Sciences Information Technology Sourcing and Vendor Management

As an increasing number of pharmaceutical companies experiment with different ways to cut costs while boosting productivity amid the pandemic, the industry is increasingly switching to cloud-based technologies. In this scenario, Veeva has become indispensable for the life sciences industry, helping life sciences enterprises manage customer databases, track drug developments, and organize clinical trials. Veeva entered the life sciences market with its Commercial Cloud business, including the core Customer Relationship Management (CRM) offering, which has now transitioned into a mature product with a market share of about 80% across all global pharmaceutical companies. Lately, Veeva has been experiencing increasing demand for its Development Cloud (R&D) suite, which now drives more than half of its total revenue. This report focuses on changing market dynamics, emerging service provider trends, and guidance on devising the right market entry strategy for Veeva services Scope Industry: life sciences Services: Veeva services Geography: global Contents This report comprises three sections, each containing insights on the Veeva services market: Veeva Systems’ product performance and future growth outlook Veeva services market size and insights on service providers The right market entry strategy for the Veeva services market Membership(s) Life Sciences Information Technology Sourcing and Vendor Management

As an increasing number of pharmaceutical companies experiment with different ways to cut costs and boost productivity amid the pandemic, the industry is increasingly switching to cloud-based technologies. In this scenario, Veeva has emerged as indispensable for the life sciences industry, helping life sciences enterprises manage customer databases, track drug developments, and organize clinical trials. Veeva’s expansion in the industry, as well as newer industries such as consumer goods, has resulted in the next wave of growth in corresponding IT services. Veeva-specific IT services is estimated to be a US$2 billion opportunity by 2025, and service providers are building strong Veeva-specific solutions to expedite clients’ time-to-market. In this report, we analyze 15 IT service providers’ Veeva services capabilities. These service providers are classified as Leaders, Major Contenders, and Aspirants based on their positioning on the Everest Group PEAK Matrix® – a composite index of distinct metrics related to a provider’s capability and market impact. Scope Industry: life sciences and pharmaceutical Geography: global Contents This report provides: An assessment of Veeva service providers on several capability and market success-related dimensions A detailed profile of each service provider, including capability overview, case studies, recent developments, and enterprise sourcing considerations Membership(s) Life Sciences Information Technology Sourcing and Vendor Management

As an increasing number of pharmaceutical companies experiment with different ways to cut costs while boosting productivity amid the pandemic, the industry is increasingly switching to cloud-based technologies. In this scenario, Veeva has become indispensable for the life sciences industry, helping life sciences enterprises manage customer databases, track drug developments, and organize clinical trials. Veeva entered the life sciences market with its Commercial Cloud business, including the core Customer Relationship Management (CRM) offering, which has now transitioned into a mature product with a market share of about 80% across all global pharma companies. Lately, Veeva has been experiencing an increasing demand for its Development Cloud (R&D) suite, which now drives more than half of its total revenue. With the changing enterprise expectations and evolving Veeva product landscape, service providers are investing in building strong Veeva-specific solutions to expedite clients’ time-to-market . In this report, we analyze 15 IT service providers’ Veeva services capabilities. These service providers are classified as Leaders, Major Contenders, and Aspirants based on their positioning on the Everest Group PEAK Matrix® – a composite index of distinct metrics related to a provider’s capability and market impact. Scope Industry: life sciences Services: Veeva services Geography: global Service providers covered: Accenture, Aqurance, Atos, BASE life science, Capgemini, Cognizant, Conexus Solutions Inc., Deloitte, EPISTA Life Science, Genpact, HCL Technologies, Infosys, NNIT, PwC, and TCS Contents This report comprises three sections, each containing insights into the Veeva service provider landscape: Market trends for Veeva services Assessment of service providers for Veeva services on several capability and market success-related dimensions Enterprise sourcing considerations, highlighting the strengths and limitations of each service provider Membership(s) Life Sciences Information Technology Sourcing and Vendor Management

The Life Sciences (LS) industry has been at the forefront of the COVID-19 response, ranging from carrying out drug trials and vaccine development to producing Personal Protective Equipment (PPE) and ventilators. There has also been a historic surge in investment in digital services such as cybersecurity, cloud migration, virtual engagement models for clinical trials and sales and marketing, and AI/ML for drug discovery. Digital transformation has become a strategic imperative for LS enterprises in a post-COVID-19 world, and they are looking for strategic partners to help them on their transformation journeys. To support enterprises, service providers are ramping up capabilities by building industry-specific tools and accelerators and engaging in life sciences-specific partnerships and co-innovation initiatives. Everest Group’s Life Sciences ITS research program analyzes service provider capabilities and the impact on the life sciences digital services market. In this research, we present a detailed assessment of 27 service providers featured on the Life Sciences Digital Services PEAK Matrix® 2021. Each assessment includes enterprise sourcing considerations, service provider ratings across metrics for market impact and vision and strategy, case studies, and recent developments. The assessment is based on Everest Group’s annual RFI process for the calendar year 2020, interactions with leading LS digital service providers, client reference checks, and an ongoing analysis of the LS digital services market. Scope We study the following service providers in this report: Accenture, Atos, Birlasoft, Capgemini, CGI, CitiusTech, Cognizant, Deloitte, DXC Technology, EPAM, Fujitsu, Genpact, HARMAN Connected Services, HCL Technologies, Hexaware, IBM, Indegene, Infostretch, Infosys, LTI, NNIT, NTT DATA, Stefanini, TCS, Tech Mahindra, Virtusa, and Wipro Contents This report comprises two key sections: Assessment of life sciences digital service providers on several capability and market success-related dimensions Detailed profile of each vendor, featuring case studies and recent developments Membership(s) Life Sciences IT Services (ITS) Sourcing and Vendor Management

The Life Sciences (LS) industry has been at the forefront of the COVID-19 response, from carrying out drug trials and vaccine development to producing Personal Protective Equipment (PPE) and ventilators. The industry was already growing significantly in digital technologies adoption and has been further pushed by the pandemic to adopt new and disruptive technologies to ensure business continuity. There is a historic surge in investment in digital services such as cybersecurity, cloud migration, virtual engagement models for clinical trials and sales and marketing, and AI/ML for drug discovery. Digital transformation has become a strategic imperative for LS enterprises in a post-COVID-19 world, and they are looking for thought leaders and strategic partners that can help them on their transformation journeys. To support enterprises on their digital journeys, service providers are ramping up capabilities, by building industry-specific tools and accelerators and engaging in life sciences-specific partnerships and co-innovation initiatives. Everest Group’s Life Sciences ITS research program analyzes service provider capabilities and their impact on the life sciences digital services market. In this report, we analyze 27 IT service providers’ digital capabilities specific to the life sciences sector. Our assessment is based on Everest Group’s annual RFI process for the calendar year 2020, interactions with leading digital service providers, client reference checks, and an in-depth analysis of the digital services market. Scope Industry: life sciences Services: digital services Geography: global Service providers covered: Accenture, Atos, Birlasoft, Capgemini, CGI, CitiusTech, Cognizant, Deloitte, DXC Technology, EPAM, Fujitsu, Genpact, HARMAN Connected Services, HCL Technologies, Hexaware, IBM, Indegene, Infostretch, Infosys, LTI, NNIT, NTT DATA, Stefanini, TCS, Tech Mahindra, Virtusa, and Wipro Contents This report comprises three sections, each containing insights about the life sciences digital service providers’ landscape, as outlined below: Digital services market trends for life sciences The landscape of service providers for life sciences digital services Assessment of service providers on several capability- and market success-related dimensions Membership(s) Life Sciences IT Services (ITS) Sourcing and Vendor Management